A glucocorticoid response element in the LTR U3 region of Friend murine leukaemia virus variant FIS-2 enhances virus production in vitro and is a major determinant for sex differences in susceptibility to FIS-2 infection in vivo
The nucleotide sequence of the Friend murine leukaemia virus variant FIS-2 LTR has high identity with the closely related Friend murine leukaemia virus (F-MuLV) LTR, except for the deletion of one direct repeat, a few point mutations and the generation of a glucocorticoid response element (GRE) in the U3 region. The GRE can mediate gene induction by glucocorticoids, mineral corticoids, progesterone and androgens, and it has been shown that incorporation of a GRE(s) within the LTR can increase the transcriptional activity of retroviral enhancers. We have previously reported an increased early virus replication in male mice compared with female mice when infected with a virus containing the FIS-2 LTR and have proposed that the GRE might contribute to this sex difference. In the present study, we introduced a single point mutation in the GRE and performed comparative studies in NIH 3T3 cells and in young adult male and female NMRI mice. We found that significantly more virus was produced from NIH 3T3 cells infected with wt FIS-2 than from cells infected with the FIS-2 GRE mutant and that this difference was further augmented by glucocorticoids. The glucocorticoid antagonist RU486 inhibited virus production in a dose-dependent manner. The wt FIS-2 disseminated significantly faster than the FIS-2 GRE mutant in both male and female mice. There was no significant difference in the dissemination rate between male and female mice infected with the FIS-2 GRE mutant. Hence, the GRE in the FIS-2 LTR is one determinant of the significant sex difference in susceptibility to FIS-2 infection.
ArcherT. K.,
LefebvreP.,
WolfordR. G.,
HagerG. L.1992; Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255:1573–1576
BrulandT.,
DaiH. Y.,
LavikL. A. S.,
KristiansenL. I.,
DalenA.2001; Gender-related differences in susceptibility, early virus dissemination and immunosuppression in mice infected with Friend murine leukaemia virus variant FIS-2. J Gen Virol 82:1821–1827
BrulandT.,
DaiH. Y.,
LavikL. A. S.,
DalenA.2003; Early dissemination rates of Friend leukaemia virus variants correlate with late pathogenesis. APMIS (in Press)
CelanderD.,
HusB. L.,
HaseltineW. A.1988; Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness. J Virol 62:1314–1322
CoffinJ. M.,
HugesS. H.,
VarmusH. E.1997; The interactions of retroviruses and their hosts. InRetroviruses pp 333–341 Edited by
CoffinJ. M.,
HugesS. H.,
VarmusH. E.
Cold Spring Habor, NY: Cold Spring Habor Laboratory;
DaiH. Y.,
FaxvaagA.,
TrosethG. I.,
AarsethH.,
DalenA.1994; Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2. J Virol 68:6976–6984
DaiH. Y.,
TrosethG. I.,
GunleksrudM.,
BrulandT.,
SolbergL. A.,
AarsethH.,
KristiansenL. I.,
DalenA.1998; Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2. J Virol 72:1244–1251
DeFrancoD.,
YamamotoK. R.1986; Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer. Mol Cell Biol 6:993–1001
DréauD.,
SonnenfeldG.,
FowlerN.,
MortonD. S.,
LyteM.1999; Effects of social conflicts on immune responses and E. coli growth within closed chambers in mice. Physiol Behav 67:133–140
GoffS. P.,
TraktmanP.,
BaltimoreD.1981; Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol 38:239–248
GoldeD. W.,
BerschN.,
LippmanM. E.,
FriendC.1979; Detection of glucocorticoid receptors on Friend erythroleukemia cells. Proc Natl Acad Sci U S A 76:3515–3517
GolemisE.,
LiY.,
HopkinsN.1990; Alignment of U3 region sequence of mammalian C-type viruses: identification of highly conserved motifs and implications for enhancer design. J Virol 64:534–542
KinoT.,
GragerovA.,
KoppJ. B.,
StauberR. H.,
PavlakisG. N.,
ChrousosG. P.1999; The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 189:51–61
KolesnitchenkoV.,
SnartR. S.1992; Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation. AIDS Res Hum Retroviruses 8:1977–1980
LylesC. M.,
DorrucciM.,
VlahovD.7 other authors1999; Longitudinal human immunodeficiency virus type 1 load in the Italian seroconversion study: correlates and temporal trends of virus load. J Infect Dis 180:1018–1024
ManleyN. R.,
O'ConnellM. A.,
SharpP. A.,
HopkinsN.1989; Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus. J Virol 63:4210–4223
MillerA. H.,
SpencerR. L.,
PearceB. D.,
PisellT. L.,
AzrieliY.,
TanapatP.,
ModayH.,
RheeR.,
McEwanB. S.1998; Glucocorticoid receptors are differently expressed in the cells and tissues of the immune system. Cell Immunol 186:45–54
MitraD.,
SikiderS. K.,
LeurenceJ.1995; Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression. Virology 214:512–521
MosmannT.1983; Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
OttenA. D.,
SandersM. M.,
McKnightG. S.1988; The MMTV LTR promotor is induced by progesterone and dihydrotestosterone but not by estrogen. Mol Endocrinol 2:143–147
PadgettD. A.,
SheridanJ. F.,
DornetJ.,
BerntsonG. G.,
CandeloraJ.,
GlaserR.1998; Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci U S A 95:7231–7235
RefaeliY.,
LevyD. N.,
WeinerD. B.1995; The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc Natl Acad Sci U S A 92:3621–3625
RussoF. O.,
PatelP. C.,
VenturaA. V.,
PereiraC. A.1999; HIV long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines. Virus Res 64:87–94
ShermanM. P.,
de NoronhaC. M. C.,
PearcheD.,
GreeneW. C.2000; Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effect on the G2 cell cycle arrest. J Virol 74:8159–8165
SoudeynsH.,
GeleziunasR.,
ShyamalaG.,
HiscottJ.,
WainbergM. A.1993; Identification of a novel glucocorticoid element within the genome of the human immunodeficiency virus type 1. Virology 194:758–768
SpeckN. A.,
BaltimoreD.1987; Six distinct nuclear factors interact with 75-base-pair direct repeat of the Moloney murine leukemia virus enhancer. Mol Cell Biol 7:503–517
SterlingT. R.,
LylesC. M.,
VlahovD.,
AstemborskiJ.1999; Sex difference in longitudinal human immunodeficiency virus type 1 levels among seroconverters. J Infect Dis 180:666–672
UdupaK. B.,
CrabtreeH. M.,
LipschitzD. A.1986; In vitro culture of proerythroblasts: characterization of proliferative response to erythropoietin and steroids. Br J Haematol 62:705–714
von LindernM.,
ZaunerW.,
MellitzerG.,
SteinleinP.,
FritschG.,
HuberK.,
LöwenbergB.,
BeugH.1999; The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Hematopoiesis 94:550–559
A glucocorticoid response element in the LTR U3 region of Friend murine leukaemia virus variant FIS-2 enhances virus production in vitro and is a major determinant for sex differences in susceptibility to FIS-2 infection in vivo